Proton pump inhibitors and an emerging epidemic of gastric fundic gland polyposis

World J Gastroenterol. 2008 Mar 7;14(9):1318-20. doi: 10.3748/wjg.14.1318.

Abstract

Fundic gland polyps are now commonly recognized during endoscopy. These polyps are benign, often multiple and usually detected in the gastric body and fundus. In the past, these polyps were sometimes associated with familial adenomatous polyposis. In recent years, it has become evident that increasing numbers of these polyps are being detected during endoscopic studies, particularly in patients treated with proton pump inhibitors for prolonged periods. In some, dysplastic changes in these polyps have also been reported. Recent studies have suggested that there may be no increase in risk of colon cancer with long-term proton pump inhibitor therapy. While temporarily reassuring, ongoing vigilance, particularly in those genetically predisposed to colon cancer, is still warranted.

Publication types

  • Review

MeSH terms

  • Adenomatous Polyposis Coli / chemically induced
  • Adenomatous Polyposis Coli / diagnosis
  • Gastric Fundus
  • Genes, APC
  • Genetic Predisposition to Disease
  • Humans
  • Polyps / chemically induced*
  • Polyps / diagnosis
  • Proton Pump Inhibitors / adverse effects*
  • Stomach Diseases / chemically induced*
  • Stomach Diseases / diagnosis

Substances

  • Proton Pump Inhibitors